These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2686306)

  • 1. [Immunomodulating therapy with myelopid in experimental Salmonella infection].
    Osmanova LIa; Gurariĭ NI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Aug; (8):94-7. PubMed ID: 2686306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the antigen-binding properties of lymphocytes in experimental Salmonella infection].
    Gurariĭ NI; Osmanova LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):88-90. PubMed ID: 3046199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and immunological studies in borderline mental disorders: problems and solutions].
    Aleksandrovskiĭ IuA; Chekhonin VP
    Vestn Ross Akad Med Nauk; 1999; (7):12-5. PubMed ID: 10467878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of myelopid in immunodeficiency states].
    Petrov RV; Borisova AM; Glazko AV; Simonova AV; Stepanenko RN
    Ter Arkh; 1990; 62(12):81-7. PubMed ID: 2084931
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of myelopid in the combined treatment of infectious-inflammatory complications in the postoperative period in neuro-oncology patients].
    Lisianyĭ NI; Romodanov SA; Radzievskiĭ AA; Rudenko VA; Pedachenko EG
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (3):16-8. PubMed ID: 1661534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of neuroendocrine disorders in traumatic toxicosis using mielopid].
    Samsonenko RA; El'skiĭ VN; Evtushenko SK; Titievskiĭ AV
    Patol Fiziol Eksp Ter; 1990; (2):28-30. PubMed ID: 2166271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunomodulating properties of a glucomacropeptide from whey. I. The stimulation of resistance in mice].
    Neĭchev Kh; Slavcheva E; Abrashev I; Todorova P; Mitov I; Veselinova D
    Acta Microbiol Bulg; 1990; 25():54-61. PubMed ID: 2200242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stimulating effect of myelopid on the regeneration of the medullary hematopoiesis in experimental acute radiation sickness].
    Deshevoĭ IuB; Moroz BB; Lebed' VG; Stepanenko RN
    Radiats Biol Radioecol; 1994; 34(4-5):561-4. PubMed ID: 7951884
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new Russian immunomodulating and anti-inflammatory preparation].
    Abidov MT; Kaliuzhin OV; Grishina TI
    Voen Med Zh; 1999 Jan; 320(1):41-5. PubMed ID: 10200624
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of using thymogen in an experimental infection caused by Yersinia enterocolitica].
    Iushchuk ND; Tseneva GIa; Alenushkina TV; Kuliashova LB
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (3):106-8. PubMed ID: 7660690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
    Vakhidova GA; Vasil'eva FR; Kurbanova RR; Stepanenko RN; Ubaĭdullaev AM
    Probl Tuberk; 1990; (3):16-8. PubMed ID: 2367502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current approaches to the prevention of infectious complications in heart surgery].
    Bogomolova NS; Abbakumov VV; Stepanenko RN; Potekhina AD; Pkhakadze TIa; Vinogradova LN
    Khirurgiia (Mosk); 1993 Feb; (2):46-53. PubMed ID: 8084151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].
    Bulava GV; Nikulina VP
    Khirurgiia (Mosk); 1996; (2):104-7. PubMed ID: 8754918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
    Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa
    Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulating action of myelopeptides in severe closed experimental craniocerebral injury in rats].
    Lisianyĭ NI; Radzhievskiĭ AA; Zakharova LA
    Biull Eksp Biol Med; 1988 Mar; 105(3):310-1. PubMed ID: 3349170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with thymogen and myelopid of patients with bronchial asthma].
    Zoloedov VI; Zemskov AM; Stupnitskiĭ AA; Goriainova TA
    Klin Med (Mosk); 1995; 73(6):43-5. PubMed ID: 8691781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From transplantation of the thymus to molecular reconstruction of the immune system].
    Arion VIa; Morozov IuI; Petrov RV; Lopukhin IuM
    Vestn Ross Akad Med Nauk; 1999; (5):15-9. PubMed ID: 10394294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective efficacy of combined administration of the multicomponent vaccine and the immunomodulator myelopid in experimental infections in mice].
    Stepanenko RN; Egorova NB; Kurbatova EA; Efremova VN; Kuz'mina LA; Skoptsova SV; Novikova EM; Kondarshova MM; Gruber IM
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):48-52. PubMed ID: 11220965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy with taktivin and myelolipid in experimental influenzal infection].
    Aleksandrova NN; Arion VIa; Slobodeniuk AV; Sanina IV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):89-92. PubMed ID: 2816187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.